BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18923476)

  • 1. The death of microarrays?
    Ledford H
    Nature; 2008 Oct; 455(7215):847. PubMed ID: 18923476
    [No Abstract]   [Full Text] [Related]  

  • 2. Technology: Read the instructions.
    Scott AR
    Nature; 2016 Sep; 537(7619):S54-6. PubMed ID: 27602740
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequencers step up to the speed challenge.
    Nature; 2006 Sep; 443(7109):258-9. PubMed ID: 16988678
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene sequencing leaves the laboratory.
    Hayden EC
    Nature; 2013 Feb; 494(7437):290-1. PubMed ID: 23426300
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA microarrays: an introduction to the technology.
    Bilitewski U
    Methods Mol Biol; 2009; 509():1-14. PubMed ID: 19212711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patents limit medical potential of sequencing.
    Merz JF
    Nature; 2002 Oct; 419(6910):878. PubMed ID: 12410280
    [No Abstract]   [Full Text] [Related]  

  • 7. [New generation sequencing in medical genetics].
    Stoppa-Lyonnet D; Houdayer C
    Med Sci (Paris); 2012 Feb; 28(2):123-4. PubMed ID: 22377291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Your genome sequence for the price of a car].
    Nau JY
    Rev Med Suisse; 2009 Aug; 5(214):1688. PubMed ID: 19772204
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA sequencers: the next generation.
    Mukhopadhyay R
    Anal Chem; 2009 Mar; 81(5):1736-40. PubMed ID: 19193124
    [No Abstract]   [Full Text] [Related]  

  • 10. China buys US sequencing firm.
    Baker M
    Nature; 2012 Sep; 489(7417):485-6. PubMed ID: 23018943
    [No Abstract]   [Full Text] [Related]  

  • 11. Automation for genomics, part two: sequencers, microarrays, and future trends.
    Meldrum D
    Genome Res; 2000 Sep; 10(9):1288-303. PubMed ID: 10984447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics: the personal side of genomics.
    Blow N
    Nature; 2007 Oct; 449(7162):627-30. PubMed ID: 17914399
    [No Abstract]   [Full Text] [Related]  

  • 13. Shift anticipated in DNA microarray market.
    Bouchie A
    Nat Biotechnol; 2002 Jan; 20(1):8. PubMed ID: 11753344
    [No Abstract]   [Full Text] [Related]  

  • 14. [A long-awaited revolution].
    Jordan B
    Med Sci (Paris); 2008 Oct; 24(10):869-73. PubMed ID: 18950585
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics firms turn to other markets.
    Hayden EC
    Nature; 2010 Feb; 463(7283):859. PubMed ID: 20164890
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomics shifts focus to rare diseases.
    Check Hayden E
    Nature; 2009 Sep; 461(7263):458. PubMed ID: 19779424
    [No Abstract]   [Full Text] [Related]  

  • 17. The beginning of the end for microarrays?
    Shendure J
    Nat Methods; 2008 Jul; 5(7):585-7. PubMed ID: 18587314
    [No Abstract]   [Full Text] [Related]  

  • 18. Personal genomes: Standard and pores.
    Sanderson K
    Nature; 2008 Nov; 456(7218):23-5. PubMed ID: 18987710
    [No Abstract]   [Full Text] [Related]  

  • 19. Has the revolution arrived?
    Collins F
    Nature; 2010 Apr; 464(7289):674-5. PubMed ID: 20360716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing in real time.
    Metzker ML
    Nat Biotechnol; 2009 Feb; 27(2):150-1. PubMed ID: 19204695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.